small molecule

ESKATA

HYDROGEN PEROXIDE

Loss of exclusivityJuly 2035latest FDA-listed patent expiry

CompanyAclaris Therapeutics →See this company's full patent-cliff portfolio

Drug detail

Brand name	ESKATA
Active ingredient	HYDROGEN PEROXIDE
Strength	40%
Dosage form	SOLUTION
Route	TOPICAL
Modality	Small molecule
FDA approval	December 2017
Marketing status	DISCN

Listed patents

Patent	Expires	Type
9675639	July 2035	product
10098910	April 2035	product
9980983	April 2035	use U-2205
10493103	April 2035	product
10729720	April 2035	product

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.